Literature DB >> 4637512

Secretion of dopa in phaeochromocytoma.

W J Louis, A E Doyle, W C Heath, M J Robinson.   

Abstract

In a series of 11 cases with phaeochromocytoma, two patients were found in whom the tumour secreted dopa in addition to dopamine, noradrenaline, and adrenaline. These two patients were normotensive in spite of high plasma and urinary levels of noradrenaline and adrenaline. This raises the possibility that dopa may be able to protect against the hypertensive action of noradrenaline. Such a mechanism would also explain the absence of hypertension in many cases of neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4637512      PMCID: PMC1786578          DOI: 10.1136/bmj.4.5836.325

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Spectrum of catechol amine biochemistry in patients with neuroblastoma.

Authors:  W VON STUDNITZ; H KASER; A SJOERDSMA
Journal:  N Engl J Med       Date:  1963-08-01       Impact factor: 91.245

2.  Catecholamine metabolism in patients with pheochromocytoma.

Authors:  A SJOERDSMA
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

3.  Phaeochromocytoma catechols in urine and tumour tissue.

Authors:  H WEIL-MALHERBE
Journal:  Lancet       Date:  1956-08-11       Impact factor: 79.321

4.  Hydroxytyramine and the adrenal medulla.

Authors:  D M SHEPHERD; G B WEST
Journal:  J Physiol       Date:  1953-04-28       Impact factor: 5.182

5.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

Review 6.  Functioning neural tumors.

Authors:  M L Voorhess
Journal:  Pediatr Clin North Am       Date:  1966-02       Impact factor: 3.278

7.  Antihypertensive and noradrenaline-depleting effects of alpha-methyl-5-hydroxytryptophan in the rat.

Authors:  R Tabei; S Spector; W J Louis; A Sjoerdsma
Journal:  Eur J Pharmacol       Date:  1969-07       Impact factor: 4.432

8.  Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.

Authors:  A M Watanabe; T N Chase; P V Cardon
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

9.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15

10.  The depressor action of dopamine and adrenaline.

Authors:  J H BURN; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1958-12
View more
  6 in total

Review 1.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Pheochromocytoma--recent advances in diagnosis and treatment.

Authors:  N L Benowitz
Journal:  West J Med       Date:  1988-05

3.  Phaeochromocytoma in childhood: report of 3 cases.

Authors:  M J Robinson; M Kent; J Stocks
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

4.  Normotensive pheochromocytoma. Pharmacologic, paraneoplastic and anesthetic considerations.

Authors:  B D Kirby; J Ham; H B Fairley; N Benowitz; M Schambelan
Journal:  West J Med       Date:  1983-08

5.  A paroxysmally secreting phaeochromocytoma: biochemical and clinical aspects.

Authors:  H Hörtnagl; D Magometschnigg; H Lochs; W Druml
Journal:  Klin Wochenschr       Date:  1983-06-15

6.  The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Authors:  Y Ito; Y Fujimoto; T Obara
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.